ArticleScientific reports2026
The association between early pregnancy infection with SARS-CoV-2 and fetal birth defects: a prospective study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
This multicenter prospective cohort study investigated the association between maternal SARS-CoV-2 infection in early pregnancy and birth defects. Although placental damage and fetal distress are known risks associated with SARS-CoV-2 infection during pregnancy, evidence regarding the impact of first-trimester infection on congenital anomalies remains limited. In this study, we prospectively enrolled 1,127 first-trimester pregnant women from three hospitals in China (535 SARS-CoV-2-infected, 592 non-infected as controls). The clinical characteristics, symptoms and treatment of COVID-19, and corresponding infant outcomes were followed-up and analyzed. Among singleton pregnancies, the incidence of total birth defects was significantly higher in the infected group than in the control group (9.2% vs. 4.7%, p = 0.004). Among the various types of birth defects, such as urinary system defects, nervous system defects, chromosome abnormality, etc., cardiovascular system malformations were the most prominent(3.4% vs. 1.5%, p = 0.048). Multivariate analysis identified first-trimester SARS-CoV-2 infection(RR = 2.25, 95%CI 1.38–3.56; p = 0.001) and twin pregnancy(RR = 4.52, 95%CI 1.83–8.95; p = 0.002) as independent risk factors. These findings demonstrate that early pregnancy SARS-CoV-2 infection correlates with an increased risk of birth defects, underscoring the need for enhanced prenatal monitoring in exposed pregnancies. The results highlight the critical importance of viral exposure timing in congenital anomaly development and support further investigation into the underlying pathogenic mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.